Atherosclerosis: the new view

Sci Am. 2002 May;286(5):46-55. doi: 10.1038/scientificamerican0502-46.
No abstract available

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Anticholesteremic Agents / therapeutic use
  • Arteries / pathology
  • Arteriosclerosis / etiology*
  • Arteriosclerosis / pathology
  • Aspirin / therapeutic use
  • C-Reactive Protein / analysis
  • Cell Adhesion Molecules
  • Chemokines
  • Cholesterol, LDL / blood
  • Endothelium, Vascular / pathology
  • Glycosylation
  • Humans
  • Hypolipidemic Agents / therapeutic use
  • Inflammation / complications
  • Inflammation / diagnosis
  • Inflammation / pathology
  • Lipid Peroxidation
  • Macrophages / pathology
  • Membrane Proteins*
  • Monocytes / pathology
  • Muscle, Smooth, Vascular
  • Myocardial Infarction / etiology
  • Receptors, Immunologic
  • Receptors, Lipoprotein*
  • Receptors, Scavenger
  • Risk Factors
  • Rupture, Spontaneous
  • Scavenger Receptors, Class B
  • Stroke / etiology
  • Thrombosis

Substances

  • Anti-Inflammatory Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anticholesteremic Agents
  • Cell Adhesion Molecules
  • Chemokines
  • Cholesterol, LDL
  • Hypolipidemic Agents
  • Membrane Proteins
  • Receptors, Immunologic
  • Receptors, Lipoprotein
  • Receptors, Scavenger
  • Scarb1 protein, mouse
  • Scavenger Receptors, Class B
  • C-Reactive Protein
  • Aspirin